Bristol-Myers Squibb Company (BMY)
Current ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 31,770,000 | 27,632,000 | 28,074,000 | 27,086,000 | 27,273,000 | 26,796,000 | 30,186,000 | 30,121,000 | 33,262,000 | 31,443,000 | 29,161,000 | 27,111,000 | 30,192,000 | 34,277,000 | 34,343,000 | 31,853,000 | 29,354,000 | 40,191,000 | 37,716,000 | 17,093,000 |
| Total current liabilities | US$ in thousands | 22,262,000 | 23,462,000 | 20,150,000 | 19,085,000 | 21,890,000 | 18,930,000 | 20,915,000 | 22,821,000 | 21,868,000 | 21,460,000 | 18,991,000 | 17,330,000 | 19,080,000 | 20,464,000 | 23,421,000 | 19,232,000 | 18,304,000 | 10,489,000 | 9,711,000 | 8,841,000 |
| Current ratio | 1.43 | 1.18 | 1.39 | 1.42 | 1.25 | 1.42 | 1.44 | 1.32 | 1.52 | 1.47 | 1.54 | 1.56 | 1.58 | 1.67 | 1.47 | 1.66 | 1.60 | 3.83 | 3.88 | 1.93 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $31,770,000K ÷ $22,262,000K
= 1.43
The current ratio of Bristol-Myers Squibb Co. has shown some fluctuations over the past eight quarters. The ratio has ranged from a low of 1.18 in Q3 2023 to a high of 1.44 in Q2 2022.
An analysis of the trend indicates that the company's current ratio has generally been above 1, which suggests that Bristol-Myers Squibb Co. has had sufficient current assets to cover its current liabilities. However, the fluctuations in the ratio indicate some variability in the company's liquidity position over the periods analyzed.
The current ratio of Bristol-Myers Squibb Co. has mostly remained within a relatively healthy range, with Q3 2023 being the lowest point and Q2 2022 being the highest. This implies that the company has managed its short-term liquidity well, with the ability to meet its current obligations.
Overall, the trend in the current ratio of Bristol-Myers Squibb Co. indicates that the company has maintained a satisfactory level of liquidity over the past eight quarters, albeit with some fluctuations. Further analysis would be required to understand the specific factors driving these changes in the current ratio and their implications for the company's financial health.
Peer comparison
Dec 31, 2023